doi.org/10.1001/jamaoncol.2019.0869, hdl.handle.net/1765/119395
JAMA oncology
Department of Gastroenterology & Hepatology

Laere, B, Rajan, P., Gronberg, H, Dirix, L., Lindberg, J., Mayrhofer, M., … Wallays, G. (2019). Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer. JAMA oncology, 5(7), 1059–1061. doi:10.1001/jamaoncol.2019.0869